Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Desogestrel 150 microgram and ethinylestradiol 25 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinyl estradiol + norgestrel 0.05mg/0.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinyl estradiol + norgestrel 0.05mg/0.5mg tablet |
Has basis of strength substance (attribute) |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cyproterone acetate and ethinylestradiol |
Causative agent (attribute) |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel 150 microgram and ethinylestradiol 25 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone acetate 1 mg oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinyl oestradiol + ethynodiol diacetate 50mcg/1mg tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol+gestodene 30micrograms/75micrograms tablet (substance) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 40 microgram and levonorgestrel 75 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norgestimate 215 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing desogestrel and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 10 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 1 mg oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 20 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and norethisterone acetate 1.5 mg oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely desogestrel 125 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol+levonorgestrel 30micrograms/250micrograms tablet (substance) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cyproterone- and ethinylestradiol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyproterone- and ethinylestradiol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and gestodene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol- and levonorgestrel-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and ferrous fumarate and norethisterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinyl estradiol + norgestrel 0.05mg/0.5mg tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and etynodiol diacetate 1 mg oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinyl estradiol + ferrous fumarate + norgestrel 0.03mg/75mg/0.3mg tablet |
Has precise active ingredient |
False |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ethinylestradiol and etynodiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet |
Has precise active ingredient |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and etynodiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and norgestrel in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and norgestimate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and norelgestromin in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and ferrous fumarate and norgestrel in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and ferrous fumarate and norgestrel (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol- and segesterone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ethinylestradiol and segesterone in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Desogestrel and ethinylestradiol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cyproterone and ethinylestradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Drospirenone and ethinylestradiol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and gestodene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and norethisterone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and ferrous fumarate and norethisterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and norgestrel only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and ferrous fumarate and norgestrel only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and levonorgestrel only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and norelgestromin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and norgestimate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and segesterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and etynodiol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and norgestimate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and etynodiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and ferrous fumarate and norgestrel only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and gestodene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and levonorgestrel in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and norelgestromin only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ethinylestradiol and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only desogestrel and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol and norgestrel only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |